biotech companies that get orphan drug status generally outperform. Oncolytics Bio fills that bill
Sentiment: Strong Buy
AF is full of #$%$. See his dopey call on gtxi.
I agree, I can't stand him but I agree with him about companies getting orphan drug status. It saves them mucho money on the trials they run